Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GALT $11.61 1.3300 +12.94%
PVCT $2.32 0.2100 +9.95%
SRNE $10.55 0.9000 +9.33%
AMBI $6.94 0.5300 +8.27%
CYTR $3.23 0.2300 +7.67%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

INO $2.52 -0.1500 -5.62%
THLD $3.83 -0.1900 -4.73%
INFI $10.15 -0.4500 -4.25%
NYMX $5.04 -0.2199 -4.18%
KPTI $31.09 -1.3100 -4.04%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next > | Last >>

Seniors Have the Most Complications After Colorectal Cancer Surgery

(CBS News) Apr 10, 2014 - The majority of colorectal cancer surgeries performed in the U.S. are on people 65 and older, and these patients tend to have worse outcomes, according to a new study from the JAMA Networks Journal.
read article 

Celgene Higher on Revlimid Patent Case Document Release

(TheStreet) Apr 9, 2014 - Celgene shares are notably higher Wednesday on what appears to be an investor relief rally over the patent life of Revlimid, the company's biggest selling cancer drug.
read article 

Hem/Onc Specialists Rank Among Highest Medicare Payees

(Medscape Medical News) Apr 9, 2014 - Specialists in hematology/oncology were the second biggest recipients of Medicare payments, at $2.09 billion dollars, split among 1831 Medicare billers.
read article (free registration required) 

How Mouse Studies Lead Medical Research Down Dead Ends

(NPR/Shots blog) Apr 8, 2014 - New drugs are usually tested in animals before they're tested in humans. But many of those studies aren't done carefully enough, analysts say. So time and money is wasted, and treatments are delayed.
read article 

Choosing Wisely Lists Dominated by Cost Considerations

(Medscape Medical News) Apr 9, 2014 - Healthcare costs figured highly in specialty medical societies' decision-making processes in determining what to include in their Choosing Wisely Top 5 lists, according to a research letter published in the April 9 issue of JAMA.
read article (free registration required) 

Fewer Americans Overwhelmed by Medical Bills: Report

(U.S. News & World Report/HealthDay News) April 9, 2014 - While millions of Americans still feel hamstrung by medical expenses, a new government report shows that some people are getting relief.
read article 

CMS Ensures Higher Value and Quality for Medicare Health and Drug Plans

( Apr 7, 2014 - Today, the Centers for Medicare & Medicaid Services (CMS) issued the 2015 rate announcement and final call letter for Medicare Advantage and prescription drug benefit (Part D) programs.
read press release 

Historic Release of Data Gives Consumers Unprecedented Transparency on the Medical Services Physicians Provide and How Much They Are Paid

( Apr 9, 2014 - Today, as part of the Obama administration’s work to make our health care system more transparent, affordable, and accountable, HHS Secretary Kathleen Sebelius announced the release of new, privacy-protected data on services and procedures provided to Medicare beneficiaries by physicians and other health care professionals.
read press release 

Docs' Medicare Pay Totals Now Public

(MedPage Today) Apr 9, 2014 - For the first time, totals of what Medicare pays individual healthcare providers is now freely available to download and browse on a government website.
read article (free registration required) 

Data Uncover Nation’s Top Medicare Billers

(Washington Post) Apr 9, 2014 - The Medicare program is the source of a small fortune for many U.S. doctors, according to a trove of government records that reveal unprecedented details about physician billing practices nationwide.
read article (free registration required) 

To Get Quality Care, You Need to be the Right Kind of Patient

(Washington Post) Apr 7, 2014 - Humphrey received excellent cancer care. All patients should be treated so considerately.
read article (free registration required) 

Becky L. DeKay, MBA, Becomes President of the Association of Community Cancer Centers

(ACCC) Apr 7, 2014 - Becky L. DeKay, MBA, became President of the Association of Community Cancer Centers at its 40th Annual National Meeting on April 2, 2014.
read press release 

Promising New Drugs, Research "Dream Teams," Cancer Risk Findings; News Roundup from AACR

(The Plain Dealer [Cleveland, OH]) Apr 9, 2014 - Wednesday marks the official end of the four-day annual meeting of the AACR in San Diego, at which more than 18,400 scientists, physicians, patient advocates and other professionals in the field of oncology convened.
read article 

Verastem Presents Data on Cancer Stem Cell-Targeting Agents at the 2014 AACR Annual Meeting

(Verastem) Apr 9, 2014 - Research results provide additional support for targeting cancer stem cells directly and through immunomodulation of the tumor microenvironment.
read corporate press release 

Clinical Data Presented at AACR Demonstrate Ability of Trovagene's Molecular Diagnostic Platform to Non-Invasively Track Cancer Patients' Response to Therapy

(Yahoo! Finance) Apr 8, 2014 - Clinical study results presented today at the AACR Annual Meeting demonstrate the ability of Trovagene's molecular diagnostic platform to detect and monitor BRAF V600E mutations in cancer patients.
read article 

Data Presented at AACR Support Potential of Peregrine's PS-Targeting Immunotherapy Bavituximab to Enhance Anti-Tumor and Immune-Stimulating Effects of Anti-CTLA-4 and Anti-PD-1 Treatments in Models of Melanoma and Colon Cancer

(MarketWatch) Apr 9, 2014 - Peregrine Pharmaceuticals, Inc., today announced data from studies validating the immune-stimulatory mechanism of action of bavituximab and demonstrating that the combination of a preclinical phosphatidylserine (PS)-targeting antibody with the immune checkpoint inhibitors anti-CTLA-4 or anti-PD-1 antibodies yielded superior anti-tumor immune responses in animal models of melanoma and colon cancer compared to anti-CTLA-4 and PD-1 antibodies alone.
read article 

ImmunoGen, Inc. Announces First Clinical Findings with Refined Dosing Strategy for IMGN853

( Apr 8, 2014 - ImmunoGen, Inc. today announced the first findings from Company research aimed at optimizing the dosing of its IMGN853 product candidate.
read article (free registration required) 

Mirna Therapeutics Announces Interim Phase 1 Safety Data on Lead Product Candidate MRX34 at AACR Annual Meeting

(Reuters) Apr 8, 2014 - MRX34 found to have manageable safety profile during initial dose-escalation phase of clinical trial in patients with unresectable primary liver cancer or solid cancers with liver involvement.
read article 

Minimal Residual Disease, Deep Sequencing, And Prognosis In Multiple Myeloma

(The Myeloma Beacon) Apr 8, 2014 - A recent Spanish study adds important findings to the growing literature about the measurement and significance of minimal residual disease in multiple myeloma.
read article 

MD Anderson Announces Immunotherapy Collaboration with GSK

(MD Anderson) Apr 8, 2014 - The University of Texas MD Anderson Cancer Center announced today it formed a research alliance with GlaxoSmithKline to strengthen its efforts in advancing therapies that train the body’s immune system to combat cancer.
read press release 

2014 Community Oncology Conference Spotlights Stark Contrasts: Exciting Advances in Treatment and Payment versus Deeping Cancer Care Crisis

(COA) Apr 9, 2014 - The theme for the just-completed 2014 Community Oncology Conference, Community Oncology 2.0: Blazing a New Way Forward, was borne out by the clinical and business presentations highlighting advances in treating cancer and in paying for cancer care.
read press release 

Nearly $5 Million in Research Grants Awarded for Innovative Pancreatic Cancer Research

(AACR) Apr 8, 2014 - The Pancreatic Cancer Action Network and the American Association for Cancer Research (AACR) awarded 14 grants through the 2014 Research Grants Program here today to outstanding scientists throughout the country, supporting their innovative research in the field of pancreatic cancer.
read press release 

NCI Intramural Research Highlighted at 2014 AACR Meeting

(NCI) Apr 7, 2014 - At this year’s annual AACR meeting in San Diego there were plenary talks by two NCI intramural scientists -- Steven Rosenberg, M.D., and Louis Staudt, M.D., Ph.D.
read article 

Statement on Forthcoming Changes in NCI's Clinical Trials Programs

(NCI) Apr 4, 2014 - Clinical trials are pivotal elements in the conversion of scientific discoveries into practical means to prevent and treat cancers.
read press statement 

ASCO Urges Congress to Provide for a Strong FDA

(ASCO in Action) Apr 9, 2014 - In written testimony to Congress on April 4, ASCO President Clifford A. Hudis, MD, FACP, urged legislators to provide appropriations of $2.784 billion to the FDA for fiscal year 2015, to strengthen and ensure access to high quality cancer care and life-saving treatments.
read article